Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 3
Submit an article Journal homepage
2,165
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

A phase II study of obinutuzumab in combination with ibrutinib for treatment of relapsed mantle cell lymphoma

Myung Sun Kima Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USAView further author information
,
Titas Banerjeea Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USAORCID Iconhttps://orcid.org/0000-0001-8077-7888View further author information
ORCID Icon,
Andy Chena Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USAView further author information
,
Alexey Danilovb City of Hope National Medical Center, Duarte, CA, USAView further author information
,
Renee MacKinnona Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USAView further author information
,
Bria Thurlowa Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USAView further author information
,
Sujata Thakurtaa Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USAView further author information
,
Kirsten Orandb City of Hope National Medical Center, Duarte, CA, USAView further author information
,
Catherine Degnina Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USAView further author information
,
Byung Parka Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USAView further author information
&
Stephen E. Spurgeona Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USACorrespondence[email protected]
View further author information
 show all
Pages 722-724 | Received 15 Dec 2021, Accepted 15 Feb 2022, Published online: 09 Mar 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.